TrialArthritis & rheumatology (Hoboken, N.J.)2025

Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study.

Alan Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.